<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151335">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886989</url>
  </required_header>
  <id_info>
    <org_study_id>HE-12-52</org_study_id>
    <nct_id>NCT01886989</nct_id>
  </id_info>
  <brief_title>Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes</brief_title>
  <official_title>Postprandial Effects of Polyphenol-rich Cocoa Beverage on Glucose, Insulin, Lipids, Oxidative Stress and Inflammation in Type 2 Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oklahoma State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oklahoma State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the postprandial effects of cocoa supplementation in glucose
      and lipids, and surrogate markers of atherosclerosis in patients with type 2 diabetes. The
      investigators aim to test the hypothesis that cocoa will lower high-fat mixed meal
      breakfast-induced postprandial rise of glucose, lipids and markers of atherosclerosis in
      patients with diabetes. Randomized cross-over controlled trial, in which participants will
      be assigned to the placebo or cocoa group with breakfast meal. Patients with type 2
      diabetes(n=25) will qualify for the study. The participants will be asked to consume 2 cups
      cocoa or placebo beverage on 2 separate postprandial study days. Both groups will receive
      high-fat mixed meal breakfast on each day. Blood draws and blood pressure (including HDI)
      measurements will be conducted at fasting, 30 min, 1,2, 4 &amp; 6 hours postprandial each day
      for 2 days.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Blood pressure (mm Hg)</measure>
    <time_frame>2.5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in blood pressure and vascular function following cocoa and placebo intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose (mg/dL)</measure>
    <time_frame>2.5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in glucose levels at fasting, 30min, 1, 2, 4, &amp; 6 hours postprandial following cocoa and placebo intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Cocoa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cocoa polyphenols (960mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo powder (109mg polyphenols) in water</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cocoa polyphenols</intervention_name>
    <description>Cocoa polyphenols (960mg) reconstituted in water</description>
    <arm_group_label>Cocoa</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of type 2diabetes

        Exclusion Criteria:

          -  on insulin therapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ARPITA BASU, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ARPITA BASU, PHD</last_name>
    <phone>4057444437</phone>
    <email>arpita.basu@okstate.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Nutritional Sciences</name>
      <address>
        <city>Stillwater</city>
        <state>Oklahoma</state>
        <zip>74078</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ARPITA BASU, PHD</last_name>
      <phone>405-744-4437</phone>
      <email>arpita.basu@okstate.edu</email>
    </contact>
    <investigator>
      <last_name>ARPITA BASU, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 24, 2013</lastchanged_date>
  <firstreceived_date>June 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>cocoa polyphenols</keyword>
  <keyword>postprandial glycemia</keyword>
  <keyword>postprandial lipemia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
